Park Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$354K Buy
978
+134
+16% +$45.9K 0.21% 78
2026
Q1
$297K Sell
844
-64
-7% -$22.8K 0.29% 45
2025
Q4
$297K Sell
908
-31
-3% -$9.83K 0.21% 66
2025
Q3
$265K Sell
939
-101
-10% -$29.3K 0.21% 65
2025
Q2
$291K Sell
1,040
-59
-5% -$16.7K 0.27% 61
2025
Q1
$342K Buy
1,099
+69
+7% +$20.4K 0.4% 41
2024
Q4
$269K Buy
+1,030
New +$306K 0.32% 52

Other funds holding AMGN

Park Capital Management's AMGN Position: Q2 2026 in Review

Park Capital Management increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $45.9K and bringing the position to 978 shares worth $354K. The position accounts for 0.21% of the portfolio, ranked #78.

Park Capital Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Park Capital Management held 978 shares of Amgen worth $354K as of Q2 2026.
  • Park Capital Management bought 134 Amgen shares in Q2 2026, an estimated $45.9K.
  • Amgen made up 0.21% of Park Capital Management's portfolio in Q2 2026, its #78 holding.
  • Park Capital Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Park Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.